These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 17110155

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatic fibrogenesis.
    Guo J, Friedman SL.
    Semin Liver Dis; 2007 Nov; 27(4):413-26. PubMed ID: 17979077
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatic stellate cells as a target for the treatment of liver fibrosis.
    Bataller R, Brenner DA.
    Semin Liver Dis; 2001 Aug; 21(3):437-51. PubMed ID: 11586471
    [Abstract] [Full Text] [Related]

  • 6. Fibrosis in the liver: acute protection and chronic disease.
    Lee Y, Friedman SL.
    Prog Mol Biol Transl Sci; 2010 Aug; 97():151-200. PubMed ID: 21074733
    [Abstract] [Full Text] [Related]

  • 7. Tissue fibrosis and carcinogenesis: divergent or successive pathways dictate multiple molecular therapeutic targets for oligo decoy therapies.
    Cutroneo KR, White SL, Chiu JF, Ehrlich HP.
    J Cell Biochem; 2006 Apr 15; 97(6):1161-74. PubMed ID: 16408276
    [Abstract] [Full Text] [Related]

  • 8. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
    Gressner OA, Weiskirchen R, Gressner AM.
    Clin Chim Acta; 2007 Jun 15; 381(2):107-13. PubMed ID: 17399697
    [Abstract] [Full Text] [Related]

  • 9. Hepatic fibrosis--role of hepatic stellate cell activation.
    Safadi R, Friedman SL.
    MedGenMed; 2002 Jul 15; 4(3):27. PubMed ID: 12466770
    [Abstract] [Full Text] [Related]

  • 10. Liver extracellular matrix in health and disease.
    Bedossa P, Paradis V.
    J Pathol; 2003 Jul 15; 200(4):504-15. PubMed ID: 12845618
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Therapeutical targets for revert liver fibrosis].
    García B L, Gálvez G J, Armendáriz B J.
    Rev Med Chil; 2007 Jun 15; 135(6):783-91. PubMed ID: 17728907
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
    Friedman SL.
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec 15; 1(2):98-105. PubMed ID: 16265071
    [Abstract] [Full Text] [Related]

  • 15. Hepatic fibrosis -- overview.
    Friedman SL.
    Toxicology; 2008 Dec 30; 254(3):120-9. PubMed ID: 18662740
    [Abstract] [Full Text] [Related]

  • 16. Liver fibrosis.
    Wallace K, Burt AD, Wright MC.
    Biochem J; 2008 Apr 01; 411(1):1-18. PubMed ID: 18333835
    [Abstract] [Full Text] [Related]

  • 17. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
    Svegliati-Baroni G, De Minicis S, Marzioni M.
    Liver Int; 2008 Sep 01; 28(8):1052-64. PubMed ID: 18783548
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of fibrinolysis in chronic liver injury (with special emphasis on MMPs and TIMPs).
    Roderfeld M, Hemmann S, Roeb E.
    Z Gastroenterol; 2007 Jan 01; 45(1):25-33. PubMed ID: 17236118
    [Abstract] [Full Text] [Related]

  • 19. Reversal of hepatic fibrosis -- fact or fantasy?
    Friedman SL, Bansal MB.
    Hepatology; 2006 Feb 01; 43(2 Suppl 1):S82-8. PubMed ID: 16447275
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of liver fibrosis].
    Domínguez M, Colmenero J, Bataller R.
    Gastroenterol Hepatol; 2009 Nov 01; 32(9):627-32. PubMed ID: 19647893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.